DIVISION OF CARDIOLOGY- SUMMARY OF WEEKLY ROUNDS

Monday, September 5 - Friday, September 9, 2016

Monday, September 5: 8:00-9:00 Cardiovascular Grand Rounds No Rounds - Labour Day 12:00-1:00 Adult Congenital Cardiac Surgery Rounds No Rounds - Labour Day

Tuesday, September 6: 7:00-8:00 B6-115 UH Complex Revascularization Rounds Presenters: CV Surgeons & Interventionalists Faculty Supervisors: D. Nagpal/P. Garg OTN Event #: Learning Objectives: 56681397 1. To develop a systematic approach to interpretation of coronary angiograms. 2. To discuss interesting case examples and their management. 3. To apply an evidence-based approach to complex revascularizaton cases in order to improve outcomes. 2:00-5:30 B6-128 UH DIDACTIC EDUCATION SESSIONS: 2:00-4:00 No Seminars/Rounds - QI Half Day 4:30-5:30 B6-128 UH & Clinical Cardiology Rounds Presenter: B. Deif Faculty Supervisor: R. Bagur B6-115 UH Title of Presentation: Tachycardia Induced Cardiomyopathy Presenting Abruptly as Cardiogenic Shock Learning Objectives: 1. Mechanisms of Arrhythmia Induced Cardiomyopathy (AIC). 2. Diagnostic criteria and management of AIC. 3. Evidence and indications for percutaneous Left Ventricular Assist Devices (pLVADs) 4. Management strategies of patients with pLVADs.

Wednesday, September 7: 8:00-9:00 B6-115 UH EP Rounds: Device Rounds Presenters: Attendings & Fellows Learning Objectives: OTN Event #: 1. To develop a systematic approach to device tracings. 59379755 2. To discuss interesting case examples. 3. To review programming features and troubleshooting. 12:00-1:00 Adult Congential Cardiac Teaching Rounds Videoconference from Toronto No Rounds

Thursday, September 8: 8:00-9:00 B6-128 UH Graphics Rounds: Ambulatory Monitors Presenter: J. Roberts

Friday, September 9: 8:00-9:00 B6-115 UH EP Tracing Rounds: Case Presentations with ECG and Intra-cardiac tracings Learning Objectives: 1. To develop a systematic approach to device tracings. 2. To discuss interesting case examples. 3. To review programming features and troubleshooting.

Some of these educational activities/rounds are an Accredited Group Learning Activity (Section 1) as defined by the Maintenance of Certification program of The Royal College of Physicians and Surgeons of Canada, approved by the Division of Cardiology Education Committee - Western University.

Supported by unrestricted grants-in-aid provided by: Aegerion Pharmaceuticals (Juxtapid (lomitapide)), Amgen Canada Inc. (Repatha), AstraZeneca Canada Inc. (Brilinta (Ticagrelor)), Bayer Inc. (XARELTO® rivaroxaban tablet), Bristol-Myers Squibb Canada & Pfizer Canada Inc., (Eliquis (apixaban)), Medtronic of Canada Inc., Merck (Januvia, Janumet), Novartis Pharmaceuticals Canada Inc. (Entresto), Servier Canada Inc. (Coversyl, Viacoram)